Open Access Open Access  Restricted Access Subscription or Fee Access

Genetic Analysis of Cupressaceae phytochemicals in Various Diseases: A Review

Kanchan Suchdeva


Family Cupressaceae of plants have various medicinal properties. In this family plants like Thuja, Juniper, Cupressus, False cypress etc. already have ornamental and medicinal values. These plants are already used for diseases like diabetes, obesity, neurodegenerative disorder etc. The plants of this family are uniquely known for its anti-inflammatory, anti-cancer, anti-oxidant and anti-microbial activities. In this study, we have predicted the genetic receptors for phytochemicals of Cupressaceae family. The function of these genes are also discussed in this review. The main aim of this review is to identify the major genes that are targeted by the phytochemicals of family Cupressaceae and their involvement in the treatment of various diseases. The future analysis of the plants could have showed good affinity towards most of the receptors involved in neuronal damage of diabetic patients and make them potentially promising drug candidate for the treatment of disease.


Cupressaceae, genes, phytochemical, diabetes, genetic disorder

Full Text:



Berger, A.L., 2016. Insulin resistance and reduced brain glucose metabolism in the aetiology of Alzheimer’s disease. Journal of Insulin Resistance, 1(1), pp.1–7.

Blázquez, E., Velázquez, E., Hurtado-Carneiro, V. and Ruiz-Albusac, J.M., 2014. Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Frontiers in endocrinology, 5, p.161.

Chatterjee, B., 2017. Nose to brain drug delivery: A recent update. J. Formul. Sci. Bioavailab, 1(2).

Chatterjee, S. and Mudher, A., 2018. Alzheimer’s Disease and Type 2 Diabetes: A critical assessment of the shared pathological traits. Frontiers in neuroscience, 12, p.383.

Chen, P.H., Cheng, S.J., Lin, H.C., Lee, C.Y. and Chou, C.H., 2018. Risk factors for the progression of mild cognitive impairment in different types of neurodegenerative disorders. Behavioural neurology, 2018.

Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., da Rocha Fernandes, J.D., Ohlrogge, A.W. and Malanda, B., 2018. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice, 138, pp.271–281.

Chornenkyy, Y., Wang, W.X., Wei, A. and Nelson, P.T., 2018. Alzheimer's disease and Type 2 Diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline. Brain Pathology.

Clark, I.A. and Vissel, B., 2018. Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α‐synuclein, amyloid‐β and insulin resistance in neurodegenerative diseases. British journal of pharmacology, 175(20), pp.3859–3875.

Farooqui, A.A. and Farooqui, T., 2018. Contribution of Diabetes and Metabolic Syndrome in the Pathogenesis of Alzheimer’s Disease. In Role of the Mediterranean Diet in the Brain and Neurodegenerative Diseases (pp. 301–316).

Gray, S.M., Meijer, R.I. and Barrett, E.J., 2014. Insulin regulates brain function, but how does it get there? Diabetes, 63(12), pp.3992–3997.


  • There are currently no refbacks.